Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 172
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03464019 | Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). | ||
| NCT04718103 | A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype | ||
| NCT04091360 | A Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease | ||
| NCT07000110 | Anifrolumab Malignancy and Serious Infections Study | ||
| NCT05186324 | Fabry Patient's Experience Of PegunigaLsidasE Alfa Monthly Infusion | ||
| NCT07517445 | Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis | ||
| NCT03666780 | Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up Study | ||
| NCT03077477 | Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers | ||
| NCT03583164 | Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options | ||
| NCT04134728 | Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors | ||
| NCT06499571 | Geographic Atrophy Long-Terms Outcomes Study | ||
| NCT00660673 | Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease | ||
| NCT02734004 | A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. | ||
| NCT05030831 | Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE | ||
| NCT04027439 | Study Evaluating 5 Doses of RPL554 and Placebo in COPD Patients Via a Dry Powder Inhaler | ||
| NCT05066698 | ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects | ||
| NCT06716801 | Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain | ||
| NCT05110261 | Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China | ||
| NCT03466320 | DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2 | ||
| NCT04484935 | Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children | ||
| NCT03492554 | Electrocardiogram Clinical Validation Study | ||
| NCT04167137 | Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants | ||
| NCT03767075 | A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets) | ||
| NCT04078152 | Durvalumab Long-Term Safety and Efficacy Study | ||
| NCT07603193 | Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With Delgocitinib Cream | ||
| NCT03881488 | Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies | ||
| NCT03983980 | Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002) | ||
| NCT03980483 | Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate | ||
| NCT04206917 | MultiPulse Therapy (MPT) for AF | ||
| NCT05633407 | Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS | ||
| NCT05761444 | Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients | ||
| NCT07430917 | Safety and Efficacy of J147 in Acute Ischemic Stroke | ||
| NCT06973161 | ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors | ||
| NCT04310085 | Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites | ||
| NCT05872035 | Smartphone Enabled Hearing Study | ||
| NCT05637515 | Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity | ||
| NCT05918978 | Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS | ||
| NCT04620148 | TAK-242 in Patients With Acute Alcoholic Hepatitis | ||
| NCT04368065 | COVID-19 Active Research Experience (CARE) | ||
| NCT04151342 | CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS) | ||
| NCT03544281 | To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) | ||
| NCT05264506 | Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive | ||
| NCT04498117 | Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery | ||
| NCT02955589 | Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL) | ||
| NCT04840849 | Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults | ||
| NCT04959799 | Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections (DALBADIA) | ||
| NCT02503033 | A Study of HMPL-523 in Relapsed or Refractory Hematologic Malignancies | ||
| NCT06498128 | Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ® | ||
| NCT05243680 | An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103) | ||
| NCT04814680 | Machine-Learning Algorithm for Prediction of Blood Pressure, Glycated Haemoglobin and Estimated Glomerular Filtration Rate |
